Author Topic: (AAN) Long-term rituximab use in an MS clinic  (Read 135 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9822
  • MS diagnosed 1980
  • Location: Pacific Northwest
(AAN) Long-term rituximab use in an MS clinic
« on: April 29, 2015, 09:29:45 am »
Presented at the recent annual AAN conference in Washington, DC:

Quote
[P3.263] Experience with Long Term Rituximab Use in a Multiple Sclerosis Clinic

Megan Barra, Khac Huy Vo, James Stankiewicz
Brookline, MA, USA.

OBJECTIVE:

Examine efficacy, dosing, and safety of rituximab in a MS Clinical Cohort

BACKGROUND:

A successful phase II trial of Rituximab in MS has led to occasional off-label use. The safety and efficacy profile of Rituximab is not well established in a repeatedly dosed MS cohort.

DESIGN/METHODS:

MS patients at the Partners MS center who have received rituximab were identified. We have conducted a retrospective chart review of these patients. We have collected information on patient characteristics including MS type, rituximab dose and dates administered, relapses identified, CD19/20 counts and any safety related events.

RESULTS:

87 (38 RRMS, 13 PPMS, 36 SPMS) patients received one or more rituximab doses at our clinic. Longest duration of ongoing treatment was 5 years. Thirteen patients received a 500mg dose, the remainder 1g. No rituximab related deaths were reported. Efficacy and safety and CD19/20 data will be presented.

CONCLUSIONS:

Rituximab has been administered to many patients in our clinic. Further conclusions will be presented.

_________________
Category - MS and CNS Inflammatory Disease: Clinical Science

Session: P3: Poster Session III: MS and CNS Inflammatory Diseases: Treatment Efficacy, Safety and Tolerability (2:00 PM-6:30 PM)
Date/Time: Tuesday, April 21, 2015 - 2:00 pm

The abstract can be seen here.
« Last Edit: May 13, 2015, 04:11:20 pm by agate »
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.